The chemical class known as RELL1 Activators encompasses a diverse set of compounds that engage with signaling pathways, which can lead to the activation of the RELL1 protein. These activators do not interact directly with RELL1 but rather initiate a cascade of intracellular events through their action on various molecular targets, ultimately influencing the activity of RELL1. The primary signaling pathways involved include NF-κB and MAPK, which are central to numerous cellular processes, including those governed by the tumor necrosis factor receptor (TNFR) superfamily, to which RELL1 belongs. Modulation of these pathways by the said activators can lead to changes in gene expression, cell survival, differentiation, and immune responses, all of which are domains where RELL1 is likely to play a role.
The chemicals categorized as RELL1 Activators are typically characterized by their ability to modulate the activity of enzymes, receptors, or other proteins that are upstream of RELL1 in its signaling pathways. By altering the function of these upstream molecules, the activators can indirectly affect the status of RELL1. It is important to understand that these compounds operate within a complex network of cellular signaling and are part of a larger mechanism that controls the function of RELL1. The precise mechanisms by which these activators influence RELL1 activity involve intricate interactions with cellular signaling molecules and are subject to regulation by a myriad of other cellular processes. Despite the indirect nature of their action, these compounds are integral to the modulation of RELL1 activity within the cellular environment.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Modulates NF-κB activity, which is a downstream signaling pathway often associated with TNFR activation and could possibly activate RELL1. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Influences the NF-κB pathway through its role as an antioxidant, potentially affecting TNFR-mediated signaling that could possibly activate RELL1. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Affects NF-κB signaling, which could impact TNFR-related pathways and could possibly activate RELL1. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Interacts with multiple signaling pathways, including NF-κB, potentially altering the activity of TNFRs and could possibly activate RELL1. | ||||||
Aspirin | 50-78-2 | sc-202471 sc-202471A | 5 g 50 g | $20.00 $42.00 | 4 | |
Inhibits the NF-κB pathway, which could have downstream effects on TNFR signaling and could possibly activate RELL1. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
Targets NF-κB signaling and could modulate TNFR family receptor activities, which could possibly activate RELL1. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can affect NF-κB activity, potentially influencing TNFR-mediated pathways and could possibly activate RELL1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of the MAPK pathway, which is often activated by TNFRs, and may therefore affect RELL1 and could possibly activate it. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, part of the MAPK pathway, and could indirectly affect TNFR-related signaling and could possibly activate RELL1. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibits the NF-κB pathway and could modulate TNFR signaling, potentially impacting RELL1 and could possibly activate it. | ||||||